University of Cincinnati Medical Center Neuromuscular Medicine (Neurology)

Topics

• Myasthenia Gravis and Thymoma 29
• Amyotrophic Lateral Sclerosis Research 18
• Ion channel regulation and function 11
• Muscle Physiology and Disorders 11
• Lysosomal Storage Disorders Research 6
• HIV/AIDS Research and Interventions 5
• Inflammatory Myopathies and Dermatomyositis 4
• Epilepsy research and treatment 3
• Genetic Neurodegenerative Diseases 3
• Muscle activation and electromyography studies 3
• Botulinum Toxin and Related Neurological Disorders 2
• Coenzyme Q10 studies and effects 2

Most cited

1. Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial.

   The Lancet. Neurology · 2021 · 153 citations · Hani Kushlaf

2. Antisense oligonucleotide jacifusen for FUS-ALS: an investigator-initiated, multicentre, open-label case series.

   Lancet (London, England) · 2025 · 27 citations · Ikjae Lee

3. Efficacy and Safety of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease After 97 Weeks: A Phase 3 Randomized Clinical Trial.

   JAMA neurology · 2023 · 48 citations · Hani Kushlaf

4. Exploring preferences and decision-making about long-acting injectable HIV pre-exposure prophylaxis (PrEP) among young sexual minority men 17-24 years old.

   Scientific reports · 2023 · 26 citations · Benedikt Pleuhs

5. Genotype-phenotype correlations in valosin-containing protein disease: a retrospective muticentre study.

   Journal of neurology, neurosurgery, and psychiatry · 2022 · 37 citations · Hani Kushlaf

6. Addressing Outcome Measure Variability in Myasthenia Gravis Clinical Trials.

   Neurology · 2023 · 23 citations · Ikjae Lee